Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PSNL · against 1,216 other Healthcare companies
Ranked #895 of 1,217 · scores higher than 26% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 20–29, including PSNL · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | PSNL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -13.3% | 6.1% | 14% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 1.2% | 5.8% | 32% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 895 | 5.1B CNY (≈$714M) | 26 | 45 | |
| 895 | 1.85T JPY (≈$12.5B) | 26 | 55 | |
| 895 | 189.3B USD | 26 | 45 | |
| 895 | 207.7B USD | 26 | 18 | |
| 895 | 1.7B USD | 26 | 21 | |
| 895 | 227M USD | 26 | 24 | |
| 895 | 21.7B USD | 26 | 32 | |
| 907 | 8.6B CNY (≈$1.2B) | 25 | 50 | |
| 907 | 8.9B CNY (≈$1.2B) | 25 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score